ALLO vs GWW · rev $4.6M vs P/E 27, rev $9.76B
Allogene Therapeutics Inc (ALLO) versus WW Grainger Inc (GWW) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
WW Grainger Inc (GWW) is a industrial distribution company listed on US.
Latest reported ALLO revenue for 2026-06-30 was $4.6M. Net income was -$85.3M. ALLO currently screens at market cap $258.1M.
Latest reported GWW revenue for 2026-06-30 was $9.76B. Net income was $1.13B. GWW currently screens at market cap $50.34B and trailing P/E 26.9.
ALLO currently screens at market cap $258.1M. GWW currently screens at market cap $50.34B and trailing P/E 26.9.
Not investment advice. Open the ALLO and GWW stock pages for the full models.
Not investment advice.